EMA and FDA share inspection reports

EMA and FDA share inspection reports

The FDA has maintained confidentiality agreements with European regulators (European Medicines Agency EMA) since 2003, which have allowed for the exchange of information as part of the respective regulatory and scientific process. However, the FDA and EMA could not, under these arrangements, share full inspection reports.

Recently, FDA and EMA have signed a new confidentiality commitment that allows the sharing of information on inspections. The confidentiality commitment, which was announced on 23.Aug.2017, allows the regulators to share non-public and commercially confidential information including trade secret information relating to medicines inspections. This will contribute to a more efficient use of inspection resources, and also to strengthen the EU-US relationship.

Link to the source:

http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/08/news_detail_002800.jsp&mid=WC0b01ac058004d5c1

No Comments

Sorry, the comment form is closed at this time.

Albert Einstein:
Success = Work + Play
PharmaGCP:
Successful business = Knowledge + Quality
Get in touch with us
info@pharmagcp.com
We work closely with you and carry out research to understand your needs and wishes.